MedTrace Logo

Effects of Zinc Supplementation on Patients With Elevated Glycemic Status

NCT06807996 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2025-05-14

No results posted yet for this study

Summary

The goal of this randomized, double-blind, placebo-controlled study included patients with elevated glycemic status is to investigate whether zinc supplementation (4mg per day) has beneficial effects on controlling blood glucose.

Conditions

  • Elevated Blood Glucose

Interventions

DIETARY_SUPPLEMENT

Zinc-enriched yeast capsule

Daily zinc supplementation: zinc-enriched yeast capsules (15 mg) for a total of 6 months.

DIETARY_SUPPLEMENT

Edible yeast placebo capsule

Daily edible yeast placebo capsules (not zinc-enriched) (15 mg) for a total of 6 months.

Sponsors & Collaborators

  • Zhilei Shan

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2025-12-01
Completion
2025-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06807996 on ClinicalTrials.gov